NPR3 and cardiovascular disorder: Of note, we found that platelet NPR-C expression level is higher in subjects with a history of cardiovascular diseases and atrial fibrillation with respect to healthy subjects, thereby suggesting that subjects at high cardiovascular risk are in general more vulnerable to the effects of C2238/αANP.